Immunome Inc. — Director's Dealing 2020

Oct 2, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2020-10-01

Reporting Person: MORRIS I WISTAR III (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Convertible Preferred Stock	$		Common Stock (882475)		Direct
Series A Convertible Preferred Stock	$		Common Stock (38464)		Indirect
Warrant (right to buy)	$9.00	2023-06-02	Series A Convertible Preferred Stock (111111)		Direct

Footnotes

F1: Each share of Series A Preferred Convertible Stock is convertible at any time at the option of the holder, without payment of additional
consideration, into Common Stock, on a one-for-one basis, has no expiration date and will automatically convert into shares of Common Stock
upon the closing of the Issuer's initial public offering.

F2: The shares are held by Cotswold Foundation (the "Foundation"). the Reporting Person has voting and investment power with respect to shares held by the Foundation.

F3: Immediately exercisable.